Genevieve Kumapley, PharmD, BCOP, discusses the importance of introducing palliative care to patients at the time of diagnosis. Specifically, she describes how a multidisciplinary team approach can affect the utilization of healthcare resources. If such an approach is taken early, there is significant potential for cost savings, she suggests.
Addressing palliative care early on, and in a multidisciplinary manner, helps all stakeholders understand the goals and preferences of the patient. As part of the team approach, members of a patient’s palliative care team discuss with the patient what tests and/or treatments will or will not be beneficial, says Dr Kumapley. By having these discussions and taking into account the patient’s preferences, the patient’s palliative care team can potentially decrease the overuse of healthcare resources, which may result in cost savings.
As a pharmacist, Dr Kumapley discusses the pharmacist’s role in palliative care. Pharmacists have the opportunity to improve patient adherence by helping patients recognize adverse events and understand how to properly manage them, she says.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More